TVAX Biomedical, Inc. — Form D
TVAX Biomedical, Inc. of Olathe, KS, a company, filed a Form D exempt-offering notice with the SEC on 2012-12-13. The offering totals $6.0M, of which $2.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-12-13
- Form: D
- Accession: 0001014108-12-000143
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $6.0M
- Amount sold: $2.0M
- Remaining: $4.0M
- Minimum investment: $27K
- Investors: 29
- Date of first sale: 2012-11-28
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-188351
Issuer
- Name: TVAX Biomedical, Inc.
- CIK: 0001526959
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 10900 S. Clay Blair Blvd., Olathe, KS, 66061
- Phone: 913-689-2953
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Philip Haworth | Executive Officer | Lenexa, KS |
| Gary W Wood | Executive Officer | Olathe, KS |
| Tammie A Wahaus | Executive Officer | Olathe, KS |
| Barry S Skikne | Director | Olathe, KS |
| Charles W Burton | Director | Olathe, KS |
| Lowell L Tilzer | Director | Olathe, KS |
| Lowell L Tilzer | Executive Officer | Olathe, KS |
| Catherine E Lucasey | Director | Olathe, KS |
| Catherine E Lucasey | Executive Officer | Olathe, KS |
| Wesley E Griffitt | Director | Olathe, KS |
| Gary W Wood | Director | Olathe, KS |
| Rex E Wiggins | Director | Lenexa, KS |
| Rex E Wiggins | Executive Officer | Lenexa, KS |
Other filings by this issuer (2)
More